March 15, 2005
Avastin for Lung Cancer
Avastin, a groundbreaking anti-angiogenesis drug, significantly improves survival in patients with advanced non-small cell lung cancer, the most common form of lung cancer.
Avastin, a groundbreaking anti-angiogenesis drug, significantly improves survival in patients with advanced non-small cell lung cancer, the most common form of lung cancer.